“The Short-Term Efficacy of a Monoclonal Antibody Fragment (brolucizumab) for Treating Neovascular Age-Related Macular Degeneration”. 2024. Ukrainian Journal of Ophthalmology , no. 3 (July): 28-32. https://doi.org/10.31288/oftalmolzh202432832.